Full-Time

Workforce Management Solutions Architect

UKG

Deadline 9/21/26
CVS Health

CVS Health

10,001+ employees

Healthcare, insurance, PBM, and retail pharmacy

Compensation Overview

$106.6k - $284.3k/yr

+ Bonus + Commission + Short-term incentive + Equity award

Company Historically Provides H1B Sponsorship

New Mexico, USA + 51 more

More locations: Washington, USA | Kansas, USA | Pennsylvania, USA | North Dakota, USA | Oregon, USA | Delaware, USA | Iowa, USA | California, USA | Washington, DC, USA | Vermont, USA | Wyoming, USA | Connecticut, USA | Texas, USA | Montana, USA | Florida, USA | New Hampshire, USA | Nevada, USA | South Carolina, USA | South Dakota, USA | Georgia, USA | Arizona, USA | Mississippi, USA | Tennessee, USA | Virginia, USA | Arkansas, USA | Minnesota, USA | Colorado, USA | Nebraska, USA | Rhode Island, USA | Utah, USA | Scottsdale, AZ, USA | Hartford, CT, USA | Kentucky, USA | West Virginia, USA | New York, NY, USA | Maryland, USA | Wisconsin, USA | Woonsocket, RI, USA | Maine, USA | Massachusetts, USA | North Carolina, USA | Oklahoma, USA | Missouri, USA | Ohio, USA | New Jersey, USA | Indiana, USA | Louisiana, USA | Michigan, USA | Illinois, USA | Alabama, USA | Idaho, USA

Remote

Bachelor's

Category
IT Operations (1)
Required Skills
Agile
Data Visualization
Forecasting
Workday HRIS
JIRA
Data Analysis

Get referred to CVS Health

See people who can refer or advise you

Requirements
  • At least 7 years of experience delivering Workforce Management solutions with deep expertise in forecasting, staffing, and scheduling.
  • At least 7 years of experience working with Workforce Management scheduling constructs, including rules, templates, shifts, and optimization constraints, as well as forecasting concepts such as demand-modeling inputs, scenarios, and overrides.
  • At least 6 years of experience configuring, customizing, and debugging Workforce Management solutions.
  • At least 5 years of experience with large enterprise Workforce Management platforms such as Infor Workforce Management/Workbrain, UKG, Legion, or similar tools.
  • At least 3 years of experience partnering with software-as-a-service vendors to deliver business outcomes.
  • At least 3 years of experience working in Agile environments, including change management and vendor negotiation.
  • At least 3 years of experience demonstrating communication and stakeholder leadership skills, with the ability to drive decisions, manage competing priorities, and drive execution.
  • At least 2 years of experience demonstrating analytical problem-solving and decision-making skills, with a track record of delivering scalable solutions.
  • At least 2 years of experience developing self and others.
  • A bachelor's degree or equivalent combination of education, training, and professional experience.
Responsibilities
  • Lead discovery workshops with business stakeholders to understand demand drivers, arrival patterns and seasonality, labor standards, staffing strategies, and scheduling pain points, and translate findings into actionable requirements and priorities.
  • Drive fit-gap analysis across vendor and product options and current-state tools, and recommend the appropriate functional approach with clear tradeoffs and decision rationale.
  • Design forecasting workflows and the operating model, including inputs, assumptions, scenarios, overrides, and governance, to produce reliable demand and staffing plans.
  • Define scheduling design patterns, including shift templates, rules, segment windows, trial schedule sets, and schedule optimization constraints, while ensuring designs support business realities and compliance.
  • Establish solution guardrails for accuracy, auditability, and transparency, including validation of totals, handling exceptions and anomalies, and performing what-if analysis.
  • Partner with engineering and technology leads to convert functional designs into configuration and build plans covering configuration, custom extensions, reporting, automation, and integrations.
  • Own functional delivery, including configuring and customizing vendor applications to meet business needs.
  • Drive end-to-end lifecycle execution for enhancements, defects, and releases, and ensure documentation and artifacts are maintained in standard tracking tools and processes.
  • Define reporting and analytics needs across forecasting accuracy, staffing versus plan, schedule adherence and coverage, and operational outcomes, and partner on dashboards and operational reporting.
  • Serve as the functional point leader across human resources, operations, and technology teams, driving alignment, decisions, and adoption.
  • Support training strategy and enablement materials for planners, schedulers, and managers to ensure new processes and tools are understood and adopted.
  • Ensure adherence to industry best practices and engage with the Workforce Management community on the latest advancements.
  • Deliver enhancements, project requests, and defects on time with optimal and scalable solutions.
  • Maintain accountability for the health of the product.
  • Challenge partners to think differently about Workforce Management business processes and operational issues, act as a thought partner, and model creative problem-solving to influence business decisions.
  • Provide strategic direction and guidance to the product team and shared services teams, with accountability for mentoring and developing team members.
Desired Qualifications
  • Experience integrating Workforce Management platforms with human resources systems such as Workday and downstream consumers of schedule and time data.
  • Experience with emerging technologies such as artificial intelligence in Workforce Management, automation, and digital employee experience platforms.
  • Reporting and analytics exposure, including dashboards and operational reporting, and comfort collaborating with business intelligence teams and tools.
  • Experience working in large, matrixed organizations.
  • Familiarity with Agile delivery, including Jira and user stories, project governance, and release and change management.
  • Experience leading Workforce Management strategy and execution during mergers, acquisitions, or divestitures.

CVS Health operates as a diversified health services company in the United States, organized into Health Care Benefits, Pharmacy & Consumer Wellness, and Health Services. Its offerings include medical insurance products, retail and mail-order prescription drugs, and pharmacy benefit management (PBM) services, all connected through its integrated platform. By combining insurance, retail pharmacy, PBM, and health solutions, CVS Health coordinates care and controls costs across touchpoints for individuals, employers, and government programs. The company aims to lower health care costs while improving access and health outcomes for customers.

Company Size

10,001+

Company Stage

IPO

Headquarters

Woonsocket, Rhode Island

Founded

1963

Get referred to CVS Health

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Q2 2026 revenue hit $106.1 billion, up 7.3%, with adjusted EPS $2.58.
  • CVS raised 2026 adjusted EPS guidance to $7.90-$8.10 and cash flow to $11.5 billion.
  • Walgreens' 1,200-store closures through 2027 funnel prescriptions toward CVS locations.

What critics are saying

  • FTC settlement on Caremark insulin practices forces transparency changes through 2036.
  • CVS expects 340B pressure and Caremark membership declines in 2027.
  • $175 billion liabilities and $3.12 billion annual interest burden constrain strategic flexibility.

What makes CVS Health unique

  • Caremark, Aetna, and 9,000 stores create unmatched U.S. pharmacy-insurance integration.
  • CVS handled 87 million PBM members and 37 million insured people in June 2026.
  • CVS app now prices Eli Lilly Zepbound and Mounjaro for same-day pickup.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Life Insurance

Disability Insurance

401(k) Retirement Plan

Company Equity

Wellness Program

Professional Development Budget

Paid Vacation

Paid Holidays

Company News

Yahoo Finance
Sep 12th, 2026
CVS quietly gains market share as Walgreens closes 1,200 US stores following $10B private equity sale

Walgreens is closing roughly 1,200 of its approximately 8,500 US locations through 2027, with many customers being redirected to nearby CVS pharmacies. The pattern is reshaping suburban pharmacy markets without direct competition. In August 2025, Walgreens completed a $10 billion sale to private equity firm Sycamore Partners, taking the 124-year-old chain private for the first time. Mike Motz was named chief executive, replacing Tim Wentworth. CVS is gaining market share without active expansion efforts. Federal and state rules require orderly prescription transfers when pharmacies close, often directing patients to the nearest CVS location. CVS and Walgreens together now handle nearly 40% of all US retail prescription sales. CVS benefits from owning Caremark, a dominant pharmacy benefit manager, providing vertical integration advantages.

Yahoo Finance
Aug 28th, 2026
CVS stock down 12% in a month despite 34% annual gain, faces 2027 headwinds

CVS Health stock has declined 12.3% over the past month, sitting about 15% below its 52-week high, though it remains up 34% over the trailing twelve months. The company's revenue reached approximately $415 billion, up 7.4% year-over-year. Management raised its full-year 2026 adjusted earnings per share guidance by $0.60 to a range of $7.90 to $8.10. For 2027, the company anticipates membership declines at Caremark and continued 340B programme pressure, offset by Aetna's recovery, which added over $2 billion in adjusted operating income in the first half of 2026. Management considers a 2027 adjusted EPS outlook of at least $8.44 reasonable. Historically, CVS has experienced varied recovery periods following market downturns, with some rebounds taking years rather than months.

Yahoo Finance
Aug 25th, 2026
CVS and Roche stocks could benefit from expanding GLP-1 drug market

CVS Health and Roche could benefit from the growing GLP-1 drug market, alongside current leaders Eli Lilly and Novo Nordisk. CVS Health has improved its financial performance, with second-quarter revenue rising 7.3% year-over-year to $106.1 billion and adjusted earnings per share increasing 42.5% to $2.58. The pharmacy chain offers all approved GLP-1 medicines in the US, including Eli Lilly's Zepbound and Foundayo, plus Novo Nordisk's Wegovy. CVS also provides low-cost online consultations at $29 to assess patient eligibility for GLP-1 drugs. Beyond GLP-1 initiatives, CVS is addressing previous business challenges and is positioned to capitalise on rising healthcare spending in the US over the next decade.

Yahoo Finance
Aug 19th, 2026
CVS Health appoints JPMorgan data executive to board as focus shifts to digital healthcare

CVS Health has appointed Teresa Heitsenrether, a senior executive from JPMorgan Chase with extensive data and analytics experience, to its board of directors. The move follows the resignation of board member Larry M. Robbins. The appointment signals CVS Health's focus on technology and data-driven healthcare at the governance level. The company, valued at approximately $120bn, operates an integrated healthcare model spanning insurance, pharmacy benefits, and retail services. Heitsenrether's data expertise aligns with CVS Health's strategy to leverage digital capabilities and operational efficiency across its businesses, including Aetna and Caremark. The company faces challenges including high debt levels and reimbursement pressures in a competitive market alongside UnitedHealth Group and Cigna.

Yahoo Finance
Aug 14th, 2026
CVS Health beats Q2 revenue and profit estimates but faces questions on sustainability

CVS Health reported second quarter revenue of $106.1 billion, beating analyst estimates of $99.41 billion by 6.7%. Adjusted earnings per share came in at $2.58, surpassing expectations of $1.85 by 39.4%. Management attributed strong performance to specialty pharmacy and Medicare Advantage, with CEO David Joyner noting improvements from actions taken in Aetna and Caremark. The company raised its full-year adjusted EPS guidance to $8 at the midpoint. However, analysts raised concerns about sustainability. Management acknowledged ongoing challenges in the 340B program and normalisation of script share gains from Rite Aid. To offset these headwinds, executives pointed to biosimilars and investments in service technology. The company has committed $20 billion over a decade to AI and technology investments, with operational savings already being realised.